Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum Toxin Type A on Semen Quality in BPH
NCT00894517Phase 2Completed
- Sponsor
- Allergan
- Start
- Aug 2009
- Primary completion
- Jun 2012
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of onabotulinumtoxinA in benign prostatic hyperplasia (BPH), sponsored by Allergan. Started Aug 2009; status: completed.
02
Drugs
onabotulinumtoxinA
03
Conditions
benign prostatic hyperplasia (BPH)
Beyond the preview
Go deeper on NCT00894517.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00894517.